Style | Citing Format |
---|---|
MLA | Hassanzadeh M, et al.. "Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors." Journal of Biomolecular Structure and Dynamics, vol. 40, no. 1, 2022, pp. 297-311. |
APA | Hassanzadeh M, Mahernia S, Caprini G, Fossati G, Adib M, Moakedi F, Amanlou M (2022). Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors. Journal of Biomolecular Structure and Dynamics, 40(1), 297-311. |
Chicago | Hassanzadeh M, Mahernia S, Caprini G, Fossati G, Adib M, Moakedi F, Amanlou M. "Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors." Journal of Biomolecular Structure and Dynamics 40, no. 1 (2022): 297-311. |
Harvard | Hassanzadeh M et al. (2022) 'Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors', Journal of Biomolecular Structure and Dynamics, 40(1), pp. 297-311. |
Vancouver | Hassanzadeh M, Mahernia S, Caprini G, Fossati G, Adib M, Moakedi F, et al.. Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors. Journal of Biomolecular Structure and Dynamics. 2022;40(1):297-311. |
BibTex | @article{ author = {Hassanzadeh M and Mahernia S and Caprini G and Fossati G and Adib M and Moakedi F and Amanlou M}, title = {Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors}, journal = {Journal of Biomolecular Structure and Dynamics}, volume = {40}, number = {1}, pages = {297-311}, year = {2022} } |
RIS | TY - JOUR AU - Hassanzadeh M AU - Mahernia S AU - Caprini G AU - Fossati G AU - Adib M AU - Moakedi F AU - Amanlou M TI - Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors JO - Journal of Biomolecular Structure and Dynamics VL - 40 IS - 1 SP - 297 EP - 311 PY - 2022 ER - |